Northern Trust’s Medline Inc MDLN Stock Holding History

Northern Trust’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.1M	Buy	1,214,981 +748,413	+160%	+$33M	0.01%	1051
2025 Q4	$19.6M	Buy	+466,568	New	+$19.7M	﹤0.01%	1670

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Northern Trust's MDLN Position: Q1 2026 in Review

Northern Trust increased its Medline Inc (MDLN) stake by 160% in Q1 2026, buying an estimated $33M and bringing the position to 1,214,981 shares worth $54.1M. The position accounts for 0.01% of the portfolio, ranked #1051.

Northern Trust first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Northern Trust held 1,214,981 shares of Medline Inc worth $54.1M as of Q1 2026.
Northern Trust bought 748,413 Medline Inc shares in Q1 2026, an estimated $33M.
Medline Inc made up 0.01% of Northern Trust's portfolio in Q1 2026, its #1051 holding.
Northern Trust first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.